(4-oxo-3-\{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl\}-3,4-dihydrophthalazin-1-yl)acetic acid multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 zopolrestat inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and zopolrestat inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] CTD PMID:19028477 (4-oxo-3-\{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl\}-3,4-dihydrophthalazin-1-yl)acetic acid decreases activity ISO AKR1B10 (Homo sapiens) 6480464 zopolrestat results in decreased activity of AKR1B10 protein and zopolrestat results in decreased activity of AKR1B10 protein mutant form CTD PMID:18325492 (E)-cinnamyl alcohol increases expression ISO AKR1B10 (Homo sapiens) 6480464 cinnamyl alcohol results in increased expression of AKR1B10 mRNA CTD PMID:20566472 (E,E)-2,4-hexadienal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of 2 more ... CTD PMID:21329684 (R)-acetoin increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of Acetoin CTD PMID:23295224 (R)-acetoin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2 more ... CTD PMID:23295224 1,2-dimethylhydrazine increases expression ISO Akr1b10 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of AKR1B10 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO AKR1B10 (Homo sapiens) 6480464 Dinitrochlorobenzene results in increased expression of AKR1B10 mRNA CTD PMID:20566472 13-dihydrodaunorubicin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in increased reduction of Daunorubicin] which results in increased chemical synthesis of daunorubicinol CTD PMID:19028477 17beta-estradiol decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Estradiol results in decreased expression of AKR1B10 mRNA CTD PMID:25321415 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of AKR1B10 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of AKR1B10 mRNA and [Progesterone co-treated with Estradiol] results in decreased expression of AKR1B10 mRNA CTD PMID:17404688 and PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO AKR1B10 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of AKR1B10 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKR1B10 mRNA CTD PMID:33387578 2-(chloromethyl)pyridine increases expression ISO AKR1B10 (Homo sapiens) 6480464 2-chloromethylpyridine results in increased expression of AKR1B10 mRNA CTD PMID:26198647 2-acetamidofluorene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1B10 mRNA CTD PMID:14656948 2-acetamidofluorene increases expression ISO AKR1B10 (Homo sapiens) 6480464 2-Acetylaminofluorene results in increased expression of AKR1B10 mRNA CTD PMID:26198647 2-hexenal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of 2-hexenal and AKR1B10 protein results in increased reduction of 2-hexenal metabolite CTD PMID:21329684 2-hydroxypropanoic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 Lactic Acid results in increased expression of AKR1B10 mRNA CTD PMID:20566472 2-hydroxypropanoic acid decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of AKR1B10 mRNA CTD PMID:30851411 2-palmitoylglycerol increases expression ISO AKR1B10 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of AKR1B10 mRNA CTD PMID:37199045 2-tert-butylhydroquinone increases expression ISO AKR1B10 (Homo sapiens) 6480464 2-tert-butylhydroquinone results in increased expression of AKR1B10 mRNA CTD PMID:30806763 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of AKR1B10 mRNA CTD PMID:28522335 3-Hydroxybenzo[a]pyrene increases expression ISO AKR1B10 (Homo sapiens) 6480464 3-hydroxybenzo(a)pyrene results in increased expression of AKR1B10 mRNA CTD PMID:26238291 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine decreases expression ISO AKR1B10 (Homo sapiens) 6480464 2-amino-3-methylimidazo(4 and 5-f)quinoline results in decreased expression of AKR1B10 mRNA CTD PMID:26198647 3-phenylprop-2-enal increases expression ISO AKR1B10 (Homo sapiens) 6480464 cinnamaldehyde results in increased expression of AKR1B10 mRNA CTD PMID:30806763 4,4'-methylene-bis-(2-chloroaniline) increases expression ISO AKR1B10 (Homo sapiens) 6480464 Methylenebis(chloroaniline) results in increased expression of AKR1B10 mRNA CTD PMID:26198647 4,4'-sulfonyldiphenol increases expression ISO Akr1b10 (Mus musculus) 6480464 bisphenol S results in increased expression of AKR1B10 mRNA CTD PMID:30951980 4-hydroperoxycyclophosphamide affects response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein affects the susceptibility to perfosfamide CTD PMID:18473730 4-hydroxynon-2-enal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of 4-hydroxy-2-nonenal CTD PMID:19013440 and PMID:21329684 4-hydroxynon-2-enal increases metabolic processing ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased metabolism of 4-hydroxy-2-nonenal CTD PMID:27417252 4-hydroxynon-2-enal multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 Oleanolic Acid inhibits the reaction [AKR1B10 protein results in increased metabolism of 4-hydroxy-2-nonenal] CTD PMID:27417252 4-hydroxyphenyl retinamide increases expression ISO Akr1b10 (Mus musculus) 6480464 Fenretinide results in increased expression of AKR1B10 mRNA CTD PMID:28973697 4-methylpentanal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of isocaproaldehyde CTD PMID:19013440 4-nitro-1,2-phenylenediamine increases expression ISO AKR1B10 (Homo sapiens) 6480464 1 and 2-diamino-4-nitrobenzene results in increased expression of AKR1B10 mRNA CTD PMID:26198647 5-fluorouracil affects expression ISO AKR1B10 (Homo sapiens) 6480464 Fluorouracil affects the expression of AKR1B10 mRNA CTD PMID:16584549 7,12-dimethyltetraphene increases expression ISO AKR1B10 (Homo sapiens) 6480464 9 more ... CTD PMID:26198647 9,10-phenanthroquinone increases expression ISO AKR1B10 (Homo sapiens) 6480464 9 and 10-phenanthrenequinone results in increased expression of AKR1B10 mRNA CTD PMID:24813866 9,10-phenanthroquinone increases metabolic processing ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased metabolism of 9 and 10-phenanthrenequinone CTD PMID:24813866 9-cis-retinal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of 9-cis-retinal CTD PMID:21851338 [6]-Shogaol increases expression ISO AKR1B10 (Homo sapiens) 6480464 shogaol metabolite results in increased expression of AKR1B10 protein more ... CTD PMID:25148906 acetoin increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of Acetoin CTD PMID:23295224 acetoin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2 more ... CTD PMID:23295224 acrolein affects metabolic processing ISO AKR1B10 (Homo sapiens) 6480464 Acrolein affects the metabolism of AKR1B10 protein and AKR1B10 protein affects the metabolism of Acrolein CTD PMID:17329238 and PMID:17597105 acrolein increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of Acrolein and AKR1B10 protein results in increased reduction of Acrolein metabolite CTD PMID:21329684 acrolein decreases response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased susceptibility to Acrolein CTD PMID:17329238 and PMID:17597105 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of AKR1B10 mRNA CTD PMID:23630614 and PMID:25378103 aflatoxin B1 increases expression ISO AKR1B10 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of AKR1B10 mRNA CTD PMID:32234424 all-trans-4-oxoretinal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of 4-oxoretinaldehyde CTD PMID:19014918 all-trans-dehydroretinal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of dehydroretinal CTD PMID:19014918 all-trans-retinal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of Retinaldehyde CTD PMID:19014918 all-trans-retinal increases metabolic processing ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased metabolism of Retinaldehyde CTD PMID:21329680 all-trans-retinol decreases response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased susceptibility to Vitamin A and AKR1B10 protein results in decreased susceptibility to Vitamin A metabolite CTD PMID:19014918 Aloe emodin decreases activity ISO AKR1B10 (Homo sapiens) 6480464 aloe emodin results in decreased activity of AKR1B10 protein CTD PMID:35065925 alpha-hexylcinnamaldehyde increases expression ISO AKR1B10 (Homo sapiens) 6480464 hexyl cinnamic aldehyde results in increased expression of AKR1B10 mRNA CTD PMID:20566472 amoxicillin increases expression ISO AKR1B10 (Homo sapiens) 6480464 Amoxicillin results in increased expression of AKR1B10 mRNA CTD PMID:28444390 ampicillin decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Ampicillin results in decreased expression of AKR1B10 mRNA CTD PMID:21632981 and PMID:26198647 anthranilic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 anthranilic acid results in increased expression of AKR1B10 mRNA CTD PMID:26198647 antimonite multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA CTD PMID:32076005 arsane multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1B10 mRNA CTD PMID:32525701 arsane increases expression ISO AKR1B10 (Homo sapiens) 6480464 Arsenic results in increased expression of AKR1B10 mRNA CTD PMID:36861143 arsenic atom multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1B10 mRNA CTD PMID:32525701 arsenic atom increases expression ISO AKR1B10 (Homo sapiens) 6480464 Arsenic results in increased expression of AKR1B10 mRNA CTD PMID:36861143 arsenite(3-) multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of AKR1B10 mRNA CTD PMID:32076005 arsenous acid decreases response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 atrazine increases expression EXP 6480464 Atrazine results in increased expression of AKR1B10 mRNA CTD PMID:36841081 Augmentin increases expression ISO AKR1B10 (Homo sapiens) 6480464 Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA CTD PMID:34767876 azathioprine increases expression ISO AKR1B10 (Homo sapiens) 6480464 Azathioprine results in increased expression of AKR1B10 mRNA CTD PMID:22623647 and PMID:26198647 Bandrowski's base increases expression ISO AKR1B10 (Homo sapiens) 6480464 Bandrowski's base results in increased expression of AKR1B10 mRNA CTD PMID:20566472 benzalkonium chloride increases expression ISO AKR1B10 (Homo sapiens) 6480464 Benzalkonium Compounds results in increased expression of AKR1B10 mRNA CTD PMID:30806763 benzidine increases expression ISO AKR1B10 (Homo sapiens) 6480464 benzidine results in increased expression of AKR1B10 mRNA CTD PMID:26198647 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of AKR1B10 mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO AKR1B10 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of AKR1B10 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO AKR1B10 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of AKR1B10 exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO Akr1b10 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of AKR1B10 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO AKR1B10 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of AKR1B10 mRNA and Benzo(a)pyrene results in increased expression of AKR1B10 protein CTD PMID:16545412 more ... Benzo[a]pyrene-7,8-diol multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein co-treated with NADP] results in increased oxidation of and affects the activity of benzo(a)pyrene 7 and 8-dihydrodiol CTD PMID:21910479 benzo[a]pyrene-7,8-dione multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein co-treated with NADP] results in increased reduction of and affects the activity of benzo(a)pyrene-7 and 8-dione CTD PMID:21910479 benzoic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 Benzoic Acid results in increased expression of AKR1B10 mRNA CTD PMID:20566472 bis(2-chloroethyl) sulfide increases expression ISO AKR1B10 (Homo sapiens) 6480464 Mustard Gas results in increased expression of AKR1B10 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO AKR1B10 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of AKR1B10 mRNA CTD PMID:28412506 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of AKR1B10 mRNA CTD PMID:26496021 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AKR1B10 mRNA CTD PMID:30816183 bisphenol A affects expression ISO AKR1B10 (Homo sapiens) 6480464 bisphenol A affects the expression of AKR1B10 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of AKR1B10 gene CTD PMID:28505145 bisphenol A multiple interactions ISO Akr1b10 (Mus musculus) 6480464 [potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA and [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA] CTD PMID:27082013 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AKR1B10 mRNA CTD PMID:25181051 bortezomib increases expression ISO AKR1B10 (Homo sapiens) 6480464 Bortezomib results in increased expression of AKR1B10 mRNA and Bortezomib results in increased expression of AKR1B10 protein CTD PMID:21215737 butane-2,3-diol multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2 and 3-butylene glycol CTD PMID:23295224 butane-2,3-dione increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of Diacetyl CTD PMID:23295224 butane-2,3-dione multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in increased reduction of Diacetyl] which results in increased chemical synthesis of Acetoin CTD PMID:23295224 cadmium atom increases expression ISO AKR1B10 (Homo sapiens) 6480464 Cadmium results in increased expression of AKR1B10 mRNA CTD PMID:21120746 and PMID:21172416 cadmium sulfate multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1B10 mRNA CTD PMID:18654764 captan increases expression ISO Akr1b10 (Mus musculus) 6480464 Captan results in increased expression of AKR1B10 mRNA CTD PMID:31558096 carbamazepine affects expression ISO AKR1B10 (Homo sapiens) 6480464 Carbamazepine affects the expression of AKR1B10 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Akr1b10 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 chlorambucil decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Chlorambucil results in decreased expression of AKR1B10 mRNA CTD PMID:26198647 chrysin decreases expression ISO AKR1B10 (Homo sapiens) 6480464 chrysin results in decreased expression of AKR1B10 mRNA and chrysin results in decreased expression of AKR1B10 protein CTD PMID:23994249 cinnamyl alcohol increases expression ISO AKR1B10 (Homo sapiens) 6480464 cinnamyl alcohol results in increased expression of AKR1B10 mRNA CTD PMID:20566472 ciprofibrate multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 ciprofibrate inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and ciprofibrate inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] CTD PMID:19028477 ciprofibrate decreases activity ISO AKR1B10 (Homo sapiens) 6480464 ciprofibrate results in decreased activity of AKR1B10 protein and ciprofibrate results in decreased activity of AKR1B10 protein mutant form CTD PMID:18325492 cisplatin increases expression ISO AKR1B10 (Homo sapiens) 6480464 Cisplatin results in increased expression of AKR1B10 mRNA CTD PMID:19561079 and PMID:27392435 cisplatin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of AKR1B10 mRNA CTD PMID:27392435 cisplatin decreases response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased susceptibility to Cisplatin CTD PMID:27417252 clavulanic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 Clavulanic Acid results in increased expression of AKR1B10 mRNA CTD PMID:34767876 Clofop multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 fenofibric acid inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and fenofibric acid inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] CTD PMID:19028477 Clofop decreases activity ISO AKR1B10 (Homo sapiens) 6480464 fenofibric acid results in decreased activity of AKR1B10 protein and fenofibric acid results in decreased activity of AKR1B10 protein mutant form CTD PMID:18325492 cobalt dichloride multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1B10 mRNA CTD PMID:18654764 copper atom multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of AKR1B10 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of AKR1B10 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO AKR1B10 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of AKR1B10 mRNA CTD PMID:19549813 crotonaldehyde affects metabolic processing ISO AKR1B10 (Homo sapiens) 6480464 2-butenal affects the metabolism of AKR1B10 protein CTD PMID:17597105 crotonaldehyde decreases response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased susceptibility to 2-butenal CTD PMID:17597105 crotonaldehyde increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of 2-butenal and AKR1B10 protein results in increased reduction of 2-butenal metabolite CTD PMID:21329684 cyclosporin A increases expression ISO AKR1B10 (Homo sapiens) 6480464 Cyclosporine results in increased expression of AKR1B10 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of AKR1B10 mRNA CTD PMID:27989131 D-glyceraldehyde multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein co-treated with NADP] affects the reduction of Glyceraldehyde more ... CTD PMID:17329238 and PMID:19028477 D-glyceraldehyde increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of Glyceraldehyde CTD PMID:19014918 and PMID:19028477 D-glyceraldehyde increases metabolic processing ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased metabolism of Glyceraldehyde CTD PMID:18325492 daunorubicin decreases response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased susceptibility to Daunorubicin CTD PMID:19028477 daunorubicin increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of Daunorubicin CTD PMID:19028477 daunorubicin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in increased reduction of Daunorubicin] which results in increased chemical synthesis of daunorubicinol more ... CTD PMID:19028477 DDT increases expression ISO AKR1B10 (Homo sapiens) 6480464 DDT results in increased expression of AKR1B10 mRNA CTD PMID:26198647 diarsenic trioxide decreases response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dibenzo[a,l]pyrene decreases expression ISO AKR1B10 (Homo sapiens) 6480464 dibenzo(a and l)pyrene results in decreased expression of AKR1B10 mRNA CTD PMID:31255691 diethyl maleate increases expression ISO AKR1B10 (Homo sapiens) 6480464 diethyl maleate results in increased expression of AKR1B10 mRNA CTD PMID:33545341 diethylstilbestrol increases expression ISO AKR1B10 (Homo sapiens) 6480464 Diethylstilbestrol results in increased expression of AKR1B10 mRNA CTD PMID:26198647 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO AKR1B10 (Homo sapiens) 6480464 Antimony Potassium Tartrate results in increased expression of AKR1B10 mRNA CTD PMID:28713220 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA CTD PMID:32076005 diquat increases expression ISO AKR1B10 (Homo sapiens) 6480464 Diquat results in increased expression of AKR1B10 mRNA CTD PMID:21172416 disulfiram increases expression ISO AKR1B10 (Homo sapiens) 6480464 Disulfiram results in increased expression of AKR1B10 mRNA CTD PMID:20566472 dorsomorphin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1B10 mRNA CTD PMID:27188386 doxorubicin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in decreased susceptibility to Doxorubicin] which results in increased expression of MMP2 mRNA more ... CTD PMID:25686905 doxorubicin increases expression ISO AKR1B10 (Homo sapiens) 6480464 Doxorubicin results in increased expression of AKR1B10 mRNA CTD PMID:29803840 doxorubicin decreases response to substance ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased susceptibility to Doxorubicin CTD PMID:25686905 emodin decreases activity ISO AKR1B10 (Homo sapiens) 6480464 Emodin results in decreased activity of AKR1B10 protein CTD PMID:35065925 ethanol affects expression ISO Akr1b10 (Mus musculus) 6480464 Ethanol affects the expression of AKR1B10 mRNA CTD PMID:30319688 ethoxyquin increases expression ISO AKR1B10 (Homo sapiens) 6480464 Ethoxyquin results in increased expression of AKR1B10 mRNA CTD PMID:21277289 ethoxyquin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 NFE2L2 protein promotes the reaction [Ethoxyquin results in increased expression of AKR1B10 mRNA] CTD PMID:21277289 Ethyl 1-benzyl-3-hydroxy- 2-oxo[5H]pyrrole-4-carboxylate decreases activity ISO AKR1B10 (Homo sapiens) 6480464 ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate results in decreased activity of AKR1B10 protein CTD PMID:18325492 Ethyl 1-benzyl-3-hydroxy- 2-oxo[5H]pyrrole-4-carboxylate multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] CTD PMID:19028477 Ethyl acrylate increases expression ISO AKR1B10 (Homo sapiens) 6480464 ethyl acrylate results in increased expression of AKR1B10 mRNA CTD PMID:26198647 eugenol increases expression ISO AKR1B10 (Homo sapiens) 6480464 Eugenol results in increased expression of AKR1B10 mRNA CTD PMID:20566472 more ... farnesal increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of farnesal CTD PMID:21187079 farnesol increases chemical synthesis ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased chemical synthesis of Farnesol CTD PMID:21187079 fenofibrate multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 Fenofibrate inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and Fenofibrate inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] CTD PMID:19028477 fenofibrate decreases activity ISO AKR1B10 (Homo sapiens) 6480464 Fenofibrate results in decreased activity of AKR1B10 protein and Fenofibrate results in decreased activity of AKR1B10 protein mutant form CTD PMID:18325492 Fidarestat affects binding ISO AKR1B10 (Homo sapiens) 6480464 NADP binds to AKR1B10 protein mutant form binds to fidarestat CTD PMID:23295227 Fidarestat multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 fidarestat binds to and results in decreased activity of AKR1B10 protein mutant form CTD PMID:23295227 flucloxacillin increases expression ISO AKR1B10 (Homo sapiens) 6480464 Floxacillin results in increased expression of AKR1B10 mRNA CTD PMID:28444390 folpet increases expression ISO Akr1b10 (Mus musculus) 6480464 folpet results in increased expression of AKR1B10 mRNA CTD PMID:31558096 formaldehyde decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of AKR1B10 mRNA CTD PMID:27664576 formononetin increases expression ISO AKR1B10 (Homo sapiens) 6480464 formononetin results in increased expression of AKR1B10 mRNA CTD PMID:37793997 Frangulin A decreases activity ISO AKR1B10 (Homo sapiens) 6480464 frangulin A results in decreased activity of AKR1B10 protein CTD PMID:35065925 Frangulin B decreases activity ISO AKR1B10 (Homo sapiens) 6480464 frangulin B results in decreased activity of AKR1B10 protein CTD PMID:35065925 furan increases expression EXP 6480464 furan results in increased expression of AKR1B10 mRNA CTD PMID:25539665 gemfibrozil decreases activity ISO AKR1B10 (Homo sapiens) 6480464 Gemfibrozil results in decreased activity of AKR1B10 protein mutant form CTD PMID:18325492 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of AKR1B10 mRNA CTD PMID:33387578 geranylgeraniol increases chemical synthesis ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased chemical synthesis of geranylgeraniol CTD PMID:21187079 glyceraldehyde multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein co-treated with NADP] affects the reduction of Glyceraldehyde more ... CTD PMID:17329238 and PMID:19028477 glyceraldehyde increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of Glyceraldehyde CTD PMID:19014918 and PMID:19028477 glyceraldehyde increases metabolic processing ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased metabolism of Glyceraldehyde CTD PMID:18325492 gold atom increases expression ISO AKR1B10 (Homo sapiens) 6480464 Gold results in increased expression of AKR1B10 mRNA CTD PMID:29705079 gold(0) increases expression ISO AKR1B10 (Homo sapiens) 6480464 Gold results in increased expression of AKR1B10 mRNA CTD PMID:29705079 hexane increases expression ISO AKR1B10 (Homo sapiens) 6480464 n-hexane results in increased expression of AKR1B10 mRNA CTD PMID:20566472 hexane-2,3-dione multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in increased reduction of 2 and 3-hexanedione] which results in increased chemical synthesis of Hexanones CTD PMID:23295224 hexane-2,3-dione increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of 2 and 3-hexanedione CTD PMID:23295224 hydrogen peroxide affects expression ISO AKR1B10 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of AKR1B10 mRNA CTD PMID:23410634 hydroquinone decreases expression ISO AKR1B10 (Homo sapiens) 6480464 hydroquinone results in decreased expression of AKR1B10 mRNA CTD PMID:31256213 indan-1-ol increases oxidation ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased oxidation of 1-indanol CTD PMID:19013440 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of AKR1B10 mRNA CTD PMID:36868495 isoeugenol increases expression ISO AKR1B10 (Homo sapiens) 6480464 isoeugenol results in increased expression of AKR1B10 mRNA CTD PMID:20566472 isoniazide increases expression ISO AKR1B10 (Homo sapiens) 6480464 Isoniazid results in increased expression of AKR1B10 mRNA CTD PMID:28444390 Isoxanthohumol decreases activity ISO AKR1B10 (Homo sapiens) 6480464 isoxanthohumol results in decreased activity of AKR1B10 protein CTD PMID:35065925 L-ascorbic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 Ascorbic Acid results in increased expression of AKR1B10 mRNA CTD PMID:26198647 lead(II) chloride multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of AKR1B10 mRNA CTD PMID:18654764 lead(II) chloride increases expression ISO AKR1B10 (Homo sapiens) 6480464 lead chloride results in increased expression of AKR1B10 mRNA CTD PMID:18654764 Licochalcone B increases expression ISO AKR1B10 (Homo sapiens) 6480464 licochalcone B results in increased expression of AKR1B10 mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO AKR1B10 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of AKR1B10 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 LY294002 decreases expression ISO AKR1B10 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of AKR1B10 protein CTD PMID:23994249 menadione increases expression ISO AKR1B10 (Homo sapiens) 6480464 Vitamin K 3 results in increased expression of AKR1B10 mRNA CTD PMID:23410634 and PMID:34767876 methyl salicylate increases expression ISO AKR1B10 (Homo sapiens) 6480464 methyl salicylate results in increased expression of AKR1B10 mRNA CTD PMID:20566472 methylisothiazolinone increases expression ISO AKR1B10 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of AKR1B10 mRNA CTD PMID:30806763 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO AKR1B10 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of AKR1B10 mRNA CTD PMID:21215737 N-methyl-N-nitrosourea increases expression ISO Akr1b10 (Mus musculus) 6480464 Methylnitrosourea results in increased expression of AKR1B10 mRNA CTD PMID:25270620 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of AKR1B10 mRNA CTD PMID:14656948 N-Nitrosopyrrolidine increases expression ISO AKR1B10 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in increased expression of AKR1B10 mRNA CTD PMID:32234424 NADP zwitterion multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein co-treated with NADP] affects the reduction of Glyceraldehyde more ... CTD PMID:17329238 and PMID:21910479 NADP zwitterion increases activity ISO AKR1B10 (Homo sapiens) 6480464 NADP results in increased activity of AKR1B10 protein CTD PMID:23295224 NADP zwitterion affects binding ISO AKR1B10 (Homo sapiens) 6480464 NADP binds to AKR1B10 protein mutant form binds to fidarestat CTD PMID:23295227 NADP zwitterion decreases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased reduction of NADP CTD PMID:19013440 NADP(+) multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein co-treated with NADP] affects the reduction of Glyceraldehyde more ... CTD PMID:17329238 and PMID:21910479 NADP(+) increases activity ISO AKR1B10 (Homo sapiens) 6480464 NADP results in increased activity of AKR1B10 protein CTD PMID:23295224 NADP(+) affects binding ISO AKR1B10 (Homo sapiens) 6480464 NADP binds to AKR1B10 protein mutant form binds to fidarestat CTD PMID:23295227 NADP(+) decreases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in decreased reduction of NADP CTD PMID:19013440 naphthalenes multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of and affects the activity of Naphthalenes CTD PMID:21910479 nickel atom increases expression ISO AKR1B10 (Homo sapiens) 6480464 Nickel results in increased expression of AKR1B10 mRNA CTD PMID:25583101 nickel sulfate increases expression ISO AKR1B10 (Homo sapiens) 6480464 nickel sulfate results in increased expression of AKR1B10 mRNA CTD PMID:20566472 nitrososulfamethoxazole increases expression ISO AKR1B10 (Homo sapiens) 6480464 4-nitrososulfamethoxazole results in increased expression of AKR1B10 mRNA CTD PMID:28444390 O-methyleugenol increases expression ISO AKR1B10 (Homo sapiens) 6480464 methyleugenol results in increased expression of AKR1B10 mRNA CTD PMID:32234424 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of AKR1B10 mRNA CTD PMID:18417182 ochratoxin A decreases expression ISO AKR1B10 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of AKR1B10 mRNA CTD PMID:32905824 oleanolic acid multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 Oleanolic Acid inhibits the reaction [[AKR1B10 protein results in decreased susceptibility to Doxorubicin] which results in increased expression of MMP2 mRNA] more ... CTD PMID:25686905 and PMID:27417252 p-chloromercuribenzenesulfonic acid decreases activity ISO AKR1B10 (Homo sapiens) 6480464 4-Chloromercuribenzenesulfonate results in decreased activity of AKR1B10 protein CTD PMID:23261715 para-Cresidine increases expression ISO AKR1B10 (Homo sapiens) 6480464 cresidine results in increased expression of AKR1B10 mRNA CTD PMID:26198647 paracetamol decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of AKR1B10 mRNA CTD PMID:21420995 and PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of AKR1B10 mRNA CTD PMID:33387578 paraquat increases expression ISO AKR1B10 (Homo sapiens) 6480464 Paraquat results in increased expression of AKR1B10 mRNA CTD PMID:35182771 pazopanib multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 pazopanib inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA] CTD PMID:29356861 pentane-2,3-dione multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [AKR1B10 protein results in increased reduction of 2 and 3-pentanedione] which results in increased chemical synthesis of Pentanones CTD PMID:23295224 pentane-2,3-dione increases reduction ISO AKR1B10 (Homo sapiens) 6480464 AKR1B10 protein results in increased reduction of 2 and 3-pentanedione CTD PMID:23295224 perfluorohexanesulfonic acid increases expression ISO Akr1b10 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of AKR1B10 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of AKR1B10 mRNA CTD PMID:27153767 perfluorooctanoic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of AKR1B10 mRNA and perfluorooctanoic acid results in increased expression of AKR1B10 protein CTD PMID:26879310 and PMID:27153767 phenethyl caffeate decreases activity ISO AKR1B10 (Homo sapiens) 6480464 caffeic acid phenethyl ester results in decreased activity of AKR1B10 protein CTD PMID:27163852 phenobarbital affects expression ISO AKR1B10 (Homo sapiens) 6480464 Phenobarbital affects the expression of AKR1B10 mRNA CTD PMID:19084549 phenobarbital increases expression ISO AKR1B10 (Homo sapiens) 6480464 Phenobarbital results in increased expression of AKR1B10 protein CTD PMID:35881160 phenol increases expression ISO AKR1B10 (Homo sapiens) 6480464 Phenol results in increased expression of AKR1B10 mRNA CTD PMID:26198647 phenylmercury acetate increases expression ISO AKR1B10 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of AKR1B10 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1B10 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [Tetradecanoylphorbol Acetate results in increased expression of JUN mRNA] which results in decreased expression of AKR1B10 mRNA and U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of AKR1B10 mRNA] CTD PMID:25463304 phorbol 13-acetate 12-myristate decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in decreased expression of AKR1B10 mRNA and Tetradecanoylphorbol Acetate results in decreased expression of AKR1B10 protein CTD PMID:25463304 and PMID:26198647 picoxystrobin decreases expression ISO AKR1B10 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of AKR1B10 mRNA CTD PMID:33512557 pimecrolimus multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 pimecrolimus inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA] CTD PMID:29356861 pirinixic acid multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of AKR1B10 mRNA more ... CTD PMID:19028477 and PMID:19710929 pirinixic acid multiple interactions ISO Akr1b10 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of AKR1B10 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 pirinixic acid results in increased expression of AKR1B10 mRNA CTD PMID:26198647 pirinixic acid decreases activity ISO AKR1B10 (Homo sapiens) 6480464 pirinixic acid results in decreased activity of AKR1B10 protein and pirinixic acid results in decreased activity of AKR1B10 protein mutant form CTD PMID:18325492 potassium bromate multiple interactions ISO Akr1b10 (Mus musculus) 6480464 [potassium bromate co-treated with bisphenol A] affects the expression of AKR1B10 mRNA more ... CTD PMID:27082013 potassium bromate affects expression ISO Akr1b10 (Mus musculus) 6480464 potassium bromate affects the expression of AKR1B10 mRNA CTD PMID:27082013 progesterone multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of AKR1B10 mRNA CTD PMID:17404688 progesterone decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Progesterone results in decreased expression of AKR1B10 mRNA CTD PMID:17404688 propan-2-ol increases expression ISO AKR1B10 (Homo sapiens) 6480464 2-Propanol results in increased expression of AKR1B10 mRNA CTD PMID:20566472 propiconazole multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [propiconazole co-treated with tebuconazole] results in increased expression of AKR1B10 mRNA CTD PMID:30989312 propiconazole increases expression ISO AKR1B10 (Homo sapiens) 6480464 propiconazole results in increased expression of AKR1B10 mRNA CTD PMID:30989312 quercetin decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Quercetin results in decreased expression of AKR1B10 mRNA CTD PMID:21632981 quercetin increases expression ISO AKR1B10 (Homo sapiens) 6480464 Quercetin results in increased expression of AKR1B10 mRNA CTD PMID:34767876 quinolin-8-ol increases expression ISO AKR1B10 (Homo sapiens) 6480464 Oxyquinoline results in increased expression of AKR1B10 mRNA CTD PMID:21632981 and PMID:26198647 rac-lactic acid increases expression ISO AKR1B10 (Homo sapiens) 6480464 Lactic Acid results in increased expression of AKR1B10 mRNA CTD PMID:20566472 rac-lactic acid decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of AKR1B10 mRNA CTD PMID:30851411 reserpine increases expression ISO AKR1B10 (Homo sapiens) 6480464 Reserpine results in increased expression of AKR1B10 mRNA CTD PMID:26198647 resorcinol increases expression ISO AKR1B10 (Homo sapiens) 6480464 resorcinol results in increased expression of AKR1B10 mRNA CTD PMID:22623647 more ... resveratrol multiple interactions ISO Akr1b10 (Mus musculus) 6480464 [resveratrol co-treated with HMGB1 protein] results in increased expression of AKR1B10 mRNA CTD PMID:25979658 rifampicin increases expression ISO AKR1B10 (Homo sapiens) 6480464 Rifampin results in increased expression of AKR1B10 mRNA CTD PMID:29356861 rifampicin multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 pazopanib inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA] and pimecrolimus inhibits the reaction [Rifampin results in increased expression of AKR1B10 mRNA] CTD PMID:29356861 rotenone decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Rotenone results in decreased expression of AKR1B10 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO AKR1B10 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of AKR1B10 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1B10 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of AKR1B10 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO Akr1b10 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of AKR1B10 mRNA CTD PMID:19073995 silicon dioxide increases secretion ISO AKR1B10 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased secretion of AKR1B10 protein CTD PMID:25895662 silver atom increases expression ISO AKR1B10 (Homo sapiens) 6480464 Silver results in increased expression of AKR1B10 mRNA CTD PMID:26014281 silver(0) increases expression ISO AKR1B10 (Homo sapiens) 6480464 Silver results in increased expression of AKR1B10 mRNA CTD PMID:26014281 sodium arsenate multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of AKR1B10 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO AKR1B10 (Homo sapiens) 6480464 sodium arsenite results in increased expression of AKR1B10 mRNA CTD PMID:23876855 more ... sodium arsenite decreases expression ISO Akr1b10 (Mus musculus) 6480464 sodium arsenite results in decreased expression of AKR1B10 mRNA CTD PMID:37682722 sodium arsenite multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased expression of AKR1B10 mRNA CTD PMID:32076005 sodium dodecyl sulfate increases expression ISO AKR1B10 (Homo sapiens) 6480464 Sodium Dodecyl Sulfate results in increased expression of AKR1B10 mRNA CTD PMID:20566472 and PMID:30806763 sorbinil multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 sorbinil inhibits the reaction [AKR1B10 protein results in increased reduction of Daunorubicin] and sorbinil inhibits the reaction [AKR1B10 protein results in increased reduction of Glyceraldehyde] CTD PMID:19028477 sorbinil decreases activity ISO AKR1B10 (Homo sapiens) 6480464 sorbinil results in decreased activity of AKR1B10 protein CTD PMID:18325492 sulforaphane increases expression ISO AKR1B10 (Homo sapiens) 6480464 sulforaphane results in increased expression of AKR1B10 mRNA CTD PMID:24383545 more ... sulindac multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 Sulindac analog binds to and results in decreased activity of AKR1B10 protein and Sulindac binds to and results in decreased activity of AKR1B10 protein CTD PMID:25532697 sulindac sulfone multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 sulindac sulfone binds to and results in decreased activity of AKR1B10 protein CTD PMID:25532697 tebuconazole increases expression ISO AKR1B10 (Homo sapiens) 6480464 tebuconazole results in increased expression of AKR1B10 mRNA CTD PMID:30989312 tebuconazole multiple interactions ISO AKR1B10 (Homo sapiens) 6480464 [propiconazole co-treated with tebuconazole] results in increased expression of AKR1B10 mRNA CTD PMID:30989312 temozolomide decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Temozolomide results in decreased expression of AKR1B10 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO AKR1B10 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of AKR1B10 mRNA CTD PMID:23410634 and PMID:34767876 tetraphene increases expression ISO AKR1B10 (Homo sapiens) 6480464 benz(a)anthracene results in increased expression of AKR1B10 mRNA CTD PMID:22236718 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of AKR1B10 mRNA CTD PMID:23411599 and PMID:34492290 titanium dioxide decreases phosphorylation ISO AKR1B10 (Homo sapiens) 6480464 titanium dioxide results in decreased phosphorylation of AKR1B10 protein CTD PMID:21439344 trans-isoeugenol increases expression ISO AKR1B10 (Homo sapiens) 6480464 isoeugenol results in increased expression of AKR1B10 mRNA CTD PMID:20566472 Tributyltin oxide increases expression ISO AKR1B10 (Homo sapiens) 6480464 bis(tri-n-butyltin)oxide results in increased expression of AKR1B10 mRNA CTD PMID:26198647 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of AKR1B10 mRNA CTD PMID:33387578 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of AKR1B10 protein CTD PMID:32519852 troglitazone increases expression ISO AKR1B10 (Homo sapiens) 6480464 troglitazone results in increased expression of AKR1B10 mRNA CTD PMID:25572481 urethane decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Urethane results in decreased expression of AKR1B10 mRNA CTD PMID:28818685 valproic acid decreases expression ISO AKR1B10 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AKR1B10 mRNA CTD PMID:29154799 valproic acid affects expression ISO AKR1B10 (Homo sapiens) 6480464 Valproic Acid affects the expression of AKR1B10 mRNA CTD PMID:25979313 vitamin E increases expression ISO AKR1B10 (Homo sapiens) 6480464 Vitamin E results in increased expression of AKR1B10 mRNA CTD PMID:34767876
